Consumables segment by product is estimated to lead the market growth during the forecast period
According to a new market research study of “South and Central America Cell Therapy Instruments Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Cell Type, Process, and End User” The South and Central America cell therapy instruments market is expected to reach US$462.05 million in 2027 from US$1,074.99 million in 2019. The market is estimated to grow with a CAGR of 11.4% from 2020-2027. The report highlights trends prevailing in the South and Central America cell therapy instruments market and the factors driving market along with those that act as hindrances.
Based on product, the South and Central America cell therapy instruments market is further segmented into consumables, equipment, systems and software. The consumables segment held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.
Cell therapy includes the administration of somatic cell preparations by injecting or grafting into the patient's body for the treatment of diseases or traumatic damages. Several instruments are utilized to carry out cell therapy to cure diabetes, neurological disorders, related injuries, some types of cancer, bones, and joints, and genetic disorders.
The increasing research and development in cell therapy have led to unique therapeutic products in cell therapy instruments to improve the immune system and efficiently treat genetic disorders. Various market players provide several consumables such as reagents kits and enzymes, and many companies offer devices, equipment, and software to conduct a wide range of cell therapy processes.
The use of equipment is essential for producing cell therapies such as NSC, PSC, MSC, T cells, and HSC. These cell therapy products are derived from animals or human cells and thus require safe conditions from contamination. Therefore, the instruments used for cell therapies help in preventing contamination and allows scaling up the transplantation.
South and Central America cell therapy instruments market is expected to grow due to factors such as increasing need for superior treatment solutions, favorable regulatory scenarios, and increasing focus on research and development activities. Additionally, developing healthcare infrastructure and increasing investments in order to boost the research activities are projected to drive the South and Central America cell therapy instruments market during the forecast period.
Thermo Fisher Scientific Inc., Lonza, Becton, Dickinson and Company, and General Electric Company are among the leading companies operating in the South and Central America cell therapy instruments market.
The report segments in South and Central America Cell Therapy Instruments Market as follows:
By Product
By Cell Type
By Process
By End User
By Country
Reasons to Buy
According to a new market research study of “South and Central America Cell Therapy Instruments Market Forecast to 2027 - COVID-19 Impact and Analysis by Product, Cell Type, Process, and End User” The South and Central America cell therapy instruments market is expected to reach US$462.05 million in 2027 from US$1,074.99 million in 2019. The market is estimated to grow with a CAGR of 11.4% from 2020-2027. The report highlights trends prevailing in the South and Central America cell therapy instruments market and the factors driving market along with those that act as hindrances.
Based on product, the South and Central America cell therapy instruments market is further segmented into consumables, equipment, systems and software. The consumables segment held the largest share of the market in 2019, and is expected to register the highest CAGR in the market during the forecast period.
Cell therapy includes the administration of somatic cell preparations by injecting or grafting into the patient's body for the treatment of diseases or traumatic damages. Several instruments are utilized to carry out cell therapy to cure diabetes, neurological disorders, related injuries, some types of cancer, bones, and joints, and genetic disorders.
The increasing research and development in cell therapy have led to unique therapeutic products in cell therapy instruments to improve the immune system and efficiently treat genetic disorders. Various market players provide several consumables such as reagents kits and enzymes, and many companies offer devices, equipment, and software to conduct a wide range of cell therapy processes.
The use of equipment is essential for producing cell therapies such as NSC, PSC, MSC, T cells, and HSC. These cell therapy products are derived from animals or human cells and thus require safe conditions from contamination. Therefore, the instruments used for cell therapies help in preventing contamination and allows scaling up the transplantation.
South and Central America cell therapy instruments market is expected to grow due to factors such as increasing need for superior treatment solutions, favorable regulatory scenarios, and increasing focus on research and development activities. Additionally, developing healthcare infrastructure and increasing investments in order to boost the research activities are projected to drive the South and Central America cell therapy instruments market during the forecast period.
Thermo Fisher Scientific Inc., Lonza, Becton, Dickinson and Company, and General Electric Company are among the leading companies operating in the South and Central America cell therapy instruments market.
The report segments in South and Central America Cell Therapy Instruments Market as follows:
By Product
- Consumables
- Equipment
- Single-Use Equipment
- Cell Processing Equipment
- Other Equipment
- Systems and Software
By Cell Type
- Human Cells
- Differentiated Cells
- Stem Cells
- Animal Cells
By Process
- Cell Processing
- Process Monitoring and Quality Control
- Cell Preservation, Distribution, and Handling
By End User
- Research Institutes
- Life Science Research Companies
- Other End Users
By Country
- Brazil
- Argentina
- Rest of South and Central America
Reasons to Buy
- To understand the South and Central America cell therapy instruments market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America cell therapy instruments market
- Efficiently plan M&A and partnership deals in the South and Central America cell therapy instruments market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of the South and Central America cell therapy instruments market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in South and Central America.
Table of Contents
1. Introduction
3. Research Methodology
4. South and Central America Cell Therapy Instruments- Market Landscape
5. Cell Therapy Instruments Market - Key Market Dynamics
6. Cell Therapy Instruments Market -South and Central America Analysis
7. Cell Therapy Instruments Market Analysis - By Product
8. Cell Therapy Instruments Market Analysis - By Cell Type
9. Cell Therapy Instruments Market Analysis - By Process
10. Cell Therapy Instruments Market Analysis - By End User
11. Cell Therapy Instruments Market Analysis and Forecast to 2027 -South and Central America Analysis
12. Impact of COVID-19 Pandemic on Global Cell Therapy Instruments Market
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- STEMCELL Technologies Inc.
- MiltenyiBiotec
- General Electric Company
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGaA
